Enterprise Therapeutics reels in $5 mln

UK-based Enterprise Therapeutics Ltd, which focuses on researching and developing new treatments for respiratory diseases, has secured $5 million in financing. Epidarex Capital and Imperial Innovations led the round.

North AmericaUSBriefs